{"issuance_frequency":"","notes_translated":{"fr":"Le présent document a pour but de fournir des directives aux fabricants de tests sérologiques destinés à la détection du SARS-CoV-2, le virus qui cause la COVID-19. Les lignes directrices présentent des recommandations concernant les essais minimaux qui doivent être effectués pour les instruments diagnostiques du SARS-CoV-2.","en":"The purpose of this document is to provide guidance to manufacturers of serological assays intended for the detection of antibodies to SARS-CoV-2, the virus that causes COVID-19 disease. The guidance outlines recommendations regarding the minimum testing that should be performed for SARS-CoV-2 diagnostics."},"issn":"","imso_approval":"true","isbn":"","creator":"","org_section":{"fr":"","en":""},"jurisdiction":"federal","private":false,"maintainer_email":"open-ouvert@tbs-sct.gc.ca","num_tags":0,"edition":"","frequency":"as_needed","data_series_issue_identification":{"fr":"","en":""},"contributor":{"fr":"","en":""},"maintainer":null,"ready_to_publish":"true","id":"2e194e33-46a8-483a-a493-57ee6f1d802c","metadata_created":"2020-05-11T12:10:33.744876","subject":["health_and_safety"],"pspc_identification_number":"","metadata_modified":"2020-05-11T12:10:33.744882","author":null,"author_email":null,"geographic_region":[],"portal_release_date":"2020-05-11","digital_object_identifier":"","state":"active","version":null,"keywords":{"fr":["Pandémie de COVID-19","tests d'anticorps","tests sérologiques"],"en":["COVID-19 pandemic","Antibody tests","serological assays."]},"relationships_as_object":[],"creator_user_id":"4cfa9a9c-1d95-40eb-86f9-bc0c8ec45d1f","title_translated":{"fr":"Ligne directrice : Exigences relatives aux tests sérologiques d’anticorps soumis en vertu de l'arrêté d'urgence concernant la COVID-19","en":"Requirements for serological antibody tests submitted under the COVID-19 Interim Order: guidance"},"type":"info","resources":[{"cache_last_updated":null,"unique_identifier":"","package_id":"2e194e33-46a8-483a-a493-57ee6f1d802c","datastore_active":false,"character_set":"","related_type":"","state":"active","id":"cd7e4769-3555-4141-b6f1-170422b5a4a9","related_relationship":"","name_translated":{"fr":"Ligne directrice : Exigences relatives aux tests sérologiques d’anticorps soumis en vertu de l'arrêté d'urgence concernant la COVID-19","en":"Requirements for serological antibody tests submitted under the COVID-19 Interim Order: guidance"},"hash":"","description":"","format":"HTML","date_published":"","mimetype_inner":null,"url_type":null,"mimetype":null,"cache_url":null,"name":"Requirements for serological antibody tests submitted under the COVID-19 Interim Order: guidance","language":["en"],"created":"2020-05-11T12:10:33.859933","url":"https://www.canada.ca/en/health-canada/services/drugs-health-products/medical-devices/application-information/guidance-documents/covid19-requirements-serological-antibody-tests.html","last_modified":null,"position":0,"revision_id":"ab24a1a7-19eb-4d03-a719-ea031cf2db81","resource_type":"publication"},{"cache_last_updated":null,"unique_identifier":"","package_id":"2e194e33-46a8-483a-a493-57ee6f1d802c","datastore_active":false,"character_set":"","related_type":"","state":"active","id":"01d35b38-474e-4ff1-83e5-5441a29198e5","related_relationship":"","name_translated":{"fr":"Ligne directrice : Exigences relatives aux tests sérologiques d’anticorps soumis en vertu de l'arrêté d'urgence concernant la COVID-19","en":"Requirements for serological antibody tests submitted under the COVID-19 Interim Order: guidance"},"hash":"","description":"","format":"HTML","date_published":"","mimetype_inner":null,"url_type":null,"mimetype":null,"cache_url":null,"name":"Requirements for serological antibody tests submitted under the COVID-19 Interim Order: guidance","language":["fr"],"created":"2020-05-11T12:10:33.859939","url":"https://www.canada.ca/fr/sante-canada/services/medicaments-produits-sante/instruments-medicaux/information-demandes/lignes-directrices/covid19-exigences-relatives-tests-serologiques-anticorps.html","last_modified":null,"position":1,"revision_id":"ab24a1a7-19eb-4d03-a719-ea031cf2db81","resource_type":"publication"}],"place_of_publication":[],"num_resources":2,"tags":[],"spatial":"","collection":"publication","org_title_at_publication":{"fr":"Agence de la santé publique du Canada","en":"Public Health Agency of Canada"},"date_published":"2020-04-24 00:00:00","issuance":"","groups":[],"license_id":"ca-ogl-lgo","data_series_name":{"fr":"","en":""},"relationships_as_subject":[],"license_title":"Open Government Licence - Canada","restrictions":"unrestricted","organization":{"description":"","created":"2016-09-23T17:25:57.068700","title":"Public Health Agency of Canada | Agence de la santé publique du Canada","name":"phac-aspc","is_organization":true,"state":"active","image_url":"","revision_id":"96161da6-edc7-4d1d-99e0-baac9df7b3b9","type":"organization","id":"1C71053B-AA64-4646-956B-41631C396018","approval_status":"approved"},"name":"2e194e33-46a8-483a-a493-57ee6f1d802c","isopen":false,"additional_notes":{"fr":"","en":""},"departmental_identification_number":"","notes":"The purpose of this document is to provide guidance to manufacturers of serological assays intended for the detection of antibodies to SARS-CoV-2, the virus that causes COVID-19 disease. The guidance outlines recommendations regarding the minimum testing that should be performed for SARS-CoV-2 diagnostics.","owner_org":"1C71053B-AA64-4646-956B-41631C396018","program_page_url":{"fr":"","en":""},"url":null,"audience":[],"gc_catalogue_number":"","license_url":"http://open.canada.ca/en/open-government-licence-canada","series_publication_dates":{"fr":"","en":""},"title":"Requirements for serological antibody tests submitted under the COVID-19 Interim Order: guidance","revision_id":"ab24a1a7-19eb-4d03-a719-ea031cf2db81"}